QSAR and molecular modeling studies for the discovery of natural products as multi-target-directed drugs for Parkinson's disease Oct 9, 2022· Yassir Boulaamane · 0 min read Event Last updated on Oct 9, 2022 ← Enhanced accuracy in predicting drug blood-brain barrier permeability with a Machine Learning Ensemble model Oct 6, 2023 Computational studies of African Natural Products Databases to identify natural dual-target-directed antiparkinsonian drugs Dec 27, 2021 →